BiotechTube
Home/FerroptoCure/Toru Natsume
TN

Toru Natsume

Director, Ph.D. (CSO at RBI)

FerroptoCure

Therapeutic Areas

Oncology

FerroptoCure Pipeline

DrugIndicationPhase
FC001Cancer (unspecified)Phase 1
FC004Cancer (unspecified)Preclinical

Leadership Team at FerroptoCure

YO
Yuji Otsuki
CEO, M.D., Ph.D.
HS
Hideyuki Saya
Director, M.D., Ph.D.
ON
Osamu Nagano
Director, DDS., Ph.D.
NN
Nobuhiro Nishiyama
Director, Ph.D.
View full FerroptoCure profile